Washington, DC | May 23-24, 2022

Image

Following the success of the 1st Annual Psychedelic Therapeutics and Drug Development Conference in 2021, we're thrilled to be hosting the 2nd Annual event on May 23-24, 2022 in Washington, DC. This event has been organized to bring together the world’s leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

Our speakers and panelists will be covering important topics such as Clinical Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science, and New Clinical Data among other topics. This event has been designed and curated for the benefit of key stakeholders in this burgeoning area and will provide practical guidance, discussion and networking.

Conference Themes

  • Clinical trial design
  • Risk Evaluation & Mitigation Strategy (REMS)
  • Abuse potential
  • Practical use/indications
  • DEA licensure & policy considerations
  • Targets for novel drug development
  • Dosage (micro/low/high)
  • Second generation psychedelic drug design
  • FDA regulatory guidance
  • Toxicology studies and considerations

2022 Featured Speakers

Reasons to Attend

Discover, Learn & Understand

Learn about the latest developments in the field of psychedelics research and better understand the clinical path forward.

Meet, Network & Re-connect

Utilize our mobile & web-based platforms to set up meetings during our networking breaks & connect with colleagues before, during and after the event.

Navigate Regulatory & Policy Challenges

Learn about the regulatory, legal and policy challenges facing developers of psychedelic-based therapies and formulate strategies.

Conference Sponsors

Conference Partner

Image

Conference Testimonials

Who Should Attend

Chief Executive Officers
Vice Presidents
Chief Medical Officers
Business Development Professionals
Regulatory Affairs Professionals
Research Scientists
R&D Professionals
Clinical Development Professionals
Licensing Professionals
Investigators
Medical Chemists
Chemists
Pharmacists
Scientists
Study Managers
Project Managers
Scientific Officers
Professors
Ph.D./Pharm.D. Students
Health Care Practitioners
Program Officers
Investors
Analysts
Medical Directors

About Us

Arrowhead Publishers' conferences offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward.

READ MORE

Contact Details

Phone:
+1 866-945-0263

Email:
enquiries@arrowheadpublishers.com

Organized By